Uproleselan
Showing 1 - 11 of 11
Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)
Recruiting
- Acute Myeloid Leukemia
- Pediatric Cancer
- Uproleselan
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 24, 2022
Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Aug 12, 2022
COVID-19 Pneumonia Trial in Ann Arbor (Uproleselan)
Recruiting
- COVID-19 Pneumonia
- Uproleselan
-
Ann Arbor, MichiganThe University of Michigan
Dec 6, 2021
Relapsed/Refractory AML Trial in Tianjin, Hangzhou (Uproleselan, Placebo)
Recruiting
- Relapsed/Refractory AML
- Uproleselan
- Placebo
-
Tianjin, Tianjin, China
- +1 more
Nov 22, 2021
Relapsed/Refractory AML Trial in Tianjin, Hangzhou (Uproleselan)
Recruiting
- Relapsed/Refractory AML
- Uproleselan
-
Tianjin, Tianjin, China
- +1 more
Sep 14, 2021
Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)
Recruiting
- Secondary Acute Myeloid Leukemia
- Cladribine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 25, 2021
Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)
Not yet recruiting
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +2 more
- (no location specified)
Mar 3, 2022
Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Uproleselan
- Placebo
-
La Jolla, California
- +69 more
Apr 5, 2022
Healthy Subjects Trial in Ruddington (Uproleselan)
Completed
- Healthy Subjects
- Uproleselan
-
Ruddington, Nottingham, United KingdomQuotient Sciences Limited
May 13, 2019